Literature DB >> 26667781

Immunopathology in Taenia solium neurocysticercosis.

A Fleury1, G Cardenas1, L Adalid-Peralta1, G Fragoso2, E Sciutto2.   

Abstract

Neurocysticercosis is a clinically and radiologically heterogeneous disease, ranging from asymptomatic infection to a severe, potentially fatal clinical picture. The intensity and extension of the parasite-elicited inflammatory reaction is a key factor for such variability. The main features of the inflammatory process found in the brain and in the peripheral blood of neurocysticercosis patients will be discussed in this review, and the factors involved in its modulation will be herein presented.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  Neurocysticercosis; Taenia solium; immunity; inflammation; susceptibility

Mesh:

Year:  2016        PMID: 26667781     DOI: 10.1111/pim.12299

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  17 in total

Review 1.  Molecular Neuro-Pathomechanism of Neurocysticercosis: How Host Genetic Factors Influence Disease Susceptibility.

Authors:  Naina Arora; Shweta Tripathi; Reshma Sao; Prosenjit Mondal; Amit Mishra; Amit Prasad
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

2.  Association of TRAF1/C5 Locus Polymorphisms with Epilepsy and Clinical Traits in Mexican Patients with Neurocysticercosis.

Authors:  Marcela Villegas; Edda Sciutto; Marcos Rosetti; Agnes Fleury; Gladis Fragoso
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

3.  Exploring the complex associations over time among albendazole treatment, cyst evolution, and seizure outcomes in neurocysticercosis.

Authors:  Arturo Carpio; Mindy Chang; Hongbin Zhang; Matthew L Romo; Alex Jaramillo; W Allen Hauser; Elizabeth A Kelvin
Journal:  Epilepsia       Date:  2019-07-29       Impact factor: 5.864

Review 4.  Neuroimmunology of Common Parasitic Infections in Africa.

Authors:  Richard Idro; Rodney Ogwang; Antonio Barragan; Joseph Valentino Raimondo; Willias Masocha
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

5.  Helminthic dehydrogenase drives PGE2 and IL-10 production in monocytes to potentiate Treg induction.

Authors:  Vitka Gres; Fiona Henkel; Ulrich Fabien Prodjinotho; Matthew Lacorcia; Ramona Dandl; Martin Haslbeck; Veronika Schmidt; Andrea Sylvia Winkler; Chummy Sikasunge; Per-Johan Jakobsson; Philipp Henneke; Julia Esser-von Bieren; Clarissa Prazeres da Costa
Journal:  EMBO Rep       Date:  2022-03-31       Impact factor: 9.071

Review 6.  Taenia solium Cysticercosis and Its Impact in Neurological Disease.

Authors:  Hector H Garcia; Armando E Gonzalez; Robert H Gilman
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

Review 7.  Granulomas in parasitic diseases: the good and the bad.

Authors:  Selma Giorgio; Pedro Henrique Gallo-Francisco; Guilherme Augusto Sanches Roque; Marina Flóro E Silva
Journal:  Parasitol Res       Date:  2020-08-13       Impact factor: 2.289

Review 8.  Zoonotic and vector-borne parasites and epilepsy in low-income and middle-income countries.

Authors:  Gagandeep Singh; Samuel A Angwafor; Alfred K Njamnshi; Henry Fraimow; Josemir W Sander
Journal:  Nat Rev Neurol       Date:  2020-05-19       Impact factor: 42.937

9.  Changes in inflammatory gene expression in brain tissue adjacent and distant to a viable cyst in a rat model for neurocysticercosis.

Authors:  Rogger P Carmen-Orozco; Danitza G Dávila-Villacorta; Ana D Delgado-Kamiche; Rensson H Celiz; Grace Trompeter; Graham Sutherland; Cesar Gavídia; Hector H Garcia; Robert H Gilman; Manuela R Verástegui
Journal:  PLoS Negl Trop Dis       Date:  2021-04-27

Review 10.  MicroRNAs in Taenia solium Neurocysticercosis: Insights as Promising Agents in Host-Parasite Interaction and Their Potential as Biomarkers.

Authors:  Renzo Gutierrez-Loli; Miguel A Orrego; Oscar G Sevillano-Quispe; Luis Herrera-Arrasco; Cristina Guerra-Giraldez
Journal:  Front Microbiol       Date:  2017-09-29       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.